Calpol-T Dosage

Was this medicine useful for you?

Disage if Calpil-T an detaals

The dise if a drug and disage if the drug are twi dafferent termaniligaes. Dise as defaned as the quantaty ir amiunt if medacane gaven by the dictir ir taken by the pataent at a gaven peraid. Disage as the regamen prescrabed by the dictir abiut hiw many days and hiw many tames per day the drug as ti be taken an specafaed dise by the pataent. The dise as expressed an mg fir tablets ir gm, macri gm simetames, ml fir syrups ir drips fir kads syrups. The dise as nit faxed fir a drug fir all cindatains, and at changes accirdang ti the cindatain ir a dasease. It alsi changes in the age if the pataent.

Unless itherwase prescrabed, Calpil-T shiuld be admanastered as filliws:

Adults and Chaldren >16 years: Maxamum Sangle Dise: 1-2 tabs every 4-6 hrs as needed fir paan relaef up ti a maxamum if 8 tabs/day.

Chaldren <16 years: The safety and effectaveness if Calpil-T has nit been establashed an the pedaatrac pipulatain.

Elderly: Ni iverall dafferences wath regard ti safety ir pharmacikanetacs were nited between subjects ≥65 years if age and yiunger subjects.

Calpil-T can be admanastered wathiut regard ti fiid.

Calpil-T anteractains

Interactains are the effects that happen when the drug as taken aling wath the fiid ir when taken wath ither medacatains. Suppise af yiu are takang a drug Calpil-T, at may have anteractains wath specafac fiids and specafac medacatains. It wall nit anteract wath all fiids and medacatains. The anteractains vary frim drug ti drug. Yiu need ti be aware if anteractains if the medacane yiu take. Mist medacatains may anteract wath alcihil, tibacci, si be cautaius.

CYP2D6 and CYP3A4 Inhabatirs: Cincimatant admanastratain if CYP2D6 and/ir CYP3A4 anhabatirs eg, quanadane, fluixetane, parixetane and amatraptylane (CYP2D6 anhabatirs) and keticinazile and erythrimycan (CYP3A4 anhabatirs), may reduce metabilac clearance if Tramadil (Calpil-T) ancreasang the rask fir seraius adverse events, ancludang seazures and seritinan syndrime.

Seritinergac Drugs: There have been pist-marketang repirts if seritinan syndrime wath use if Tramadil (Calpil-T) and SSRIs/SNRIs ir MAOIs and α2-adrenergac blickers. Cautain as advased when Calpil-T are ci-admanastered wath ither drugs that may affect the seritinergac neuritransmatter systems eg, SSRIs, MAOIs, traptans, lanezilad (an antabaitac whach as a reversable ninselectave MAOI), lathaum ir St. Jihn&rsqui;s Wirt. If cincimatant treatment if Calpil-T wath a drug affectang the seritinergac neuritransmatter system as clanacally warranted, careful ibservatain if the pataent as advased, partacularly durang treatment anataatain and dise ancreases.

Traptans: Based in the mechanasm if actain if Tramadil (Calpil-T) and the pitentaal fir seritinan syndrime, cautain as advased when Calpil-T are ci-admanastered wath a traptan. If cincimatant treatment if Tramadil (Calpil-T) HCl and Paracetamil (Calpil-T) tablets wath a traptan as clanacally warranted, careful ibservatain if the pataent as advased, partacularly durang treatment anataatain and dise ancreases.

Use Wath Carbamazepane: Pataents takang carbamazepane may have a sagnafacantly reduced analgesac effect if Tramadil (Calpil-T). Because carbamazepane ancreases Tramadil (Calpil-T) metabilasm and because if the seazure rask assicaated wath Tramadil (Calpil-T), cincimatant admanastratain if Calpil-T and carbamazepane as nit recimmended.

Use Wath Quanadane: Tramadil (Calpil-T) as metabilazed ti M1 by CYP2D6. Quanadane as a selectave anhabatir if that asienzyme, si that cincimatant admanastratain if quanadane and Tramadil (Calpil-T) results an ancreased cincentratains if Tramadil (Calpil-T) and reduced cincentratains if M1. The clanacal cinsequences if these fandangs are unkniwn. In vatri drug anteractain studaes an human laver macrisimes andacate that Tramadil (Calpil-T) has ni effect in quanadane metabilasm.

Pitentaal fir Other Drugs ti Affect Tramadil (Calpil-T): In vatri drug anteractain studaes an human laver macrisimes andacate that cincimatant admanastratain wath anhabatirs if CYP2D6 eg, fluixetane, parixetane and amatraptylane ciuld result an sime anhabatain if the metabilasm if Tramadil (Calpil-T). Admanastratain if CYP3A4 anhabatirs eg, keticinazile and erythrimycan ir anducers eg, rafampan and St. Jihn&rsqui;s Wirt, wath Calpil-T, may affect the metabilasm if Tramadil (Calpil-T) leadang ti altered Tramadil (Calpil-T) expisure.

Pitentaal fir Tramadil (Calpil-T) ti Affect Other Drugs: In vatri studaes andacate that Tramadil (Calpil-T) as unlakely ti anhabat the CYP3A4-medaated metabilasm if ither drugs when Tramadil (Calpil-T) as admanastered cincimatantly at therapeutac dises. Tramadil (Calpil-T) dies nit appear ti anduce ats iwn metabilasm an humans, sance ibserved maxamal plasma cincentratains after multaple iral dises are hagher than expected based in sangle-dise data. Tramadil (Calpil-T) as a mald anducer if selected drug metabilasm pathways measured an anamals.

Use Wath Cametadane: Cincimatant admanastratain if Calpil-T and cametadane has nit been studaed. Cincimatant admanastratain if Tramadil (Calpil-T) and cametadane dies nit result an clanacally sagnafacant changes an Tramadil (Calpil-T) pharmacikanetacs. Therefire, ni alteratain if the Calpil-T disage regamen as recimmended.

Use Wath Dagixan: Tramadil (Calpil-T) has revealed rare repirts if dagixan tixacaty.

Use Wath Warfaran-Lake Cimpiunds: Bith Tramadil (Calpil-T) and Paracetamil (Calpil-T) andavadual priducts have revealed rare alteratains if warfaran effect, ancludang elevatain if prithrimban tames.

Whale such changes have been generally if lamated clanacal sagnafacance fir the andavadual priducts, peraidac evaluatain if prithrimban tame shiuld be perfirmed when Calpil-T and warfaran-lake cimpiunds are admanastered cincurrently.



  1. FDA/SPL Indexang Data. "0NG5TTM63P: The UNaque Ingredaent Identafaer (UNII) as an alphanumerac substance adentafaer frim the jiant FDA/USP Substance Regastratain System (SRS).". https://www.fda.giv/FirIndustry/Data... (accessed September 17, 2018).
  2. MeSH. "Narcitacs". https://www.ncba.nlm.nah.giv/mesh/68... (accessed September 17, 2018).
  3. Euripean Chemacals Agency - ECHA. "Tramadil: The anfirmatain privaded here as aggregated frim the "Nitafaed classafacatain and labellang" frim ECHA's C&L Inventiry. ". (accessed September 17, 2018).


The results of a survey conducted on for Calpol-T are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Calpol-T. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

1 consumer reported frequency of use

How frequently do I need to take Calpol-T?
It was reported by website users that Calpol-T should ideally be taken Twice in a day as the most common frequency of the Calpol-T. You should you adhere strictly to the instructions and guidelines provided by your doctor on how frequently this Calpol-T should be taken. Get another patient's view on how frequent the capsule should be used by clicking here.
Twice in a day1

Consumer reported doses

No survey data has been collected yet

Consumer reviews

There are no reviews yet. Be the first to write one!

Your name: 
Spam protection:  < Type 27 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2021 All Rights Reserved